Augmedix Inc expected to post a loss of 12 cents a share - Earnings Preview

Augmedix

04/11/2023 01:53

* Augmedix Inc  AUGX.OQ   AUGX.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The San Francisco California-based  company is expected to
report  a 45.3% increase in revenue to $11.424 million from
$7.86 million a year ago, according to the mean estimate from 5
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Augmedix Inc is for
a
loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Augmedix
Inc is
$7.25​, above​ its last closing price of $4.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.13       -0.13      -0.12     Beat    7.7
 Mar. 31 2023  -0.15       -0.15      -0.14     Beat    8.2
 Dec. 31 2022  -0.15       -0.15      -0.15     Met     2.2​
 Sep. 30 2022              -0.17                        
 ​​Jun.        -0.16       -0.15      -0.20     Missed  -29
 30 2022                                                
 Mar. 31 2022  -0.15       -0.15      -0.16     Missed  -4.9​
 Dec. 31 2021  -0.15       -0.15      -0.15     Met     3.1
 Sep. 30 2021  -0.11       -0.10      -0.19     Missed  -81
 This summary was machine generated November 4 at 01:53 GMT.  All
figures in US dollars  unless otherwise stated